402 related articles for article (PubMed ID: 23761392)
1. Determinants of immunological and virological responses to antiretroviral therapy amongst HIV-infected adults in central Argentina: negative influence of hepatitis C infection.
Farías AA; Kremer LE; Allende L; Díaz Mdel P; Pisano MB; Contigiani MS; Ré VE
Trans R Soc Trop Med Hyg; 2013 Jul; 107(7):432-7. PubMed ID: 23761392
[TBL] [Abstract][Full Text] [Related]
2. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
3. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
4. Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia.
Taye S; Lakew M
BMC Immunol; 2013 May; 14():23. PubMed ID: 23679118
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
[TBL] [Abstract][Full Text] [Related]
6. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
[TBL] [Abstract][Full Text] [Related]
7. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
[TBL] [Abstract][Full Text] [Related]
8. Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy.
Castagna A; Galli L; Torti C; D'Arminio Monforte A; Mussini C; Antinori A; Cozzi-Lepri A; Ladisa N; De Luca A; Seminari E; Gianotti N; Lazzarin A
Antivir Ther; 2010; 15(2):165-75. PubMed ID: 20386071
[TBL] [Abstract][Full Text] [Related]
9. HCV genotype distribution among HIV co-infected individuals in Argentina: relationship with host and viral factors.
Quarleri JF; Bolcic FM; Bouzas MB; Laufer N; Gómez Carrillo M; Mammana L; Kaufman S; Pérez H; Cahn P; Salomon H
Acta Gastroenterol Latinoam; 2007 Jun; 37(2):76-83. PubMed ID: 17684937
[TBL] [Abstract][Full Text] [Related]
10. HIV and hepatitis C coinfection.
Matthews GV; Dore GJ
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
[TBL] [Abstract][Full Text] [Related]
11. Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy.
Solmone M; Girardi E; Lalle E; Abbate I; D'Arminio Monforte A; Cozzi-Lepri A; Alessandrini A; Piscopo R; Ebo F; Cosco L; Antonucci G; Ippolito G; Capobianchi MR; ;
Antivir Ther; 2006; 11(1):87-94. PubMed ID: 16518964
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
da Silva CM; de Peder LD; Guelere AM; Horvath JD; Silva ES; Teixeira JJV; Bertolini DA
PLoS One; 2018; 13(9):e0203272. PubMed ID: 30192795
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with virological failure in a cohort of combination antiretroviral therapy-treated patients managed at a tertiary referral centre.
Fong R; Cheng AC; Vujovic O; Hoy JF
Sex Health; 2013 Nov; 10(5):442-7. PubMed ID: 24119435
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
Sagoe KW; Agyei AA; Ziga F; Lartey M; Adiku TK; Seshi M; Arens MQ; Mingle JA
J Med Virol; 2012 Jan; 84(1):6-10. PubMed ID: 22095533
[TBL] [Abstract][Full Text] [Related]
15. Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; Morsica G; Pizzaferri P; Ladisa N; Sighinolfi L; Chiodera A; Solmone M; Lalle E; Ippolito G; Monforte Ad; ;
Antivir Ther; 2005; 10(1):109-17. PubMed ID: 15751768
[TBL] [Abstract][Full Text] [Related]
16. Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naïve individuals in Kumasi, Ghana.
Boateng R; Mutocheluh M; Dompreh A; Obiri-Yeboah D; Odame Anto E; Owusu M; Narkwa PW
PLoS One; 2019; 14(4):e0215377. PubMed ID: 31002687
[TBL] [Abstract][Full Text] [Related]
17. Immunological and virological response to haart in HIV-1 patients co-infected with hepatitis B and C viruses.
Okwuraiwe AP; Audu RA; Salu OB; Onwuamah CK; Amoo OS; Ige FA; Meshack EH; Jamda PD; Odunukwe NN; Onwujekwe DI; Ezechi OC; Idigbe EO
West Afr J Med; 2012; 31(2):124-8. PubMed ID: 23208483
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population.
Reiche EM; Bonametti AM; Morimoto HK; Morimoto AA; Wiechemann SL; Matsuo T; Vissoci Reiche F; Vogler IH
Int J Mol Med; 2008 Mar; 21(3):387-95. PubMed ID: 18288387
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype.
Caudai C; Pianese M; Zacchini F; Toti M; Zazzi M; Valensin PE
J Clin Virol; 2005 Feb; 32(2):151-5. PubMed ID: 15653418
[TBL] [Abstract][Full Text] [Related]
20. Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection.
Kaufmann GR; Khanna N; Weber R; Perrin L; Furrer H; Cavassini M; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
Antivir Ther; 2004 Apr; 9(2):263-74. PubMed ID: 15134189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]